Dec 19, 2024 8:30am EST Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
Dec 4, 2024 8:30am EST Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast
Sep 25, 2024 CEO Dr. Adam Mendelsohn presented at the Emerging Growth Conference on September 25, 2024.
Sep 24, 2024 CEO Dr. Adam Mendelsohn joined Daniel Levine on the September 24, 2024 installment of The Bio Report podcast to discuss Vivani Medical’s implantable drug delivery technology, how it works, and why its lead indication is a GLP-1 implant for weight loss and diabetes.